For patients undergoing surgery for elbow trauma, treatment with the hemostatic drug tranexamic acid (TXA) is associated with a decreased incidence of heterotopic ossification (HO) – a common complication of abnormal bone formation, reports a study in The Journal of Bone & Joint Surgery.
Orasis snags $78M to launch presbyopia eye drops more than a year after FDA approval
Last October was an FDA approval. This October is a $68 million fundraising round. Next year, maybe a drug launch. Orasis Pharmaceuticals … Sign up
October 9, 2024